Longterm outcome of endoscopic sclerotherapy of variceal bleeding: Comparative study between schistosomiasis and others

Hepato-Gastroenterology

Volumn 43, Issue 7, 1996, Pages 287-292

  Al Karawi, Mohamed Ali ^a   Mohamed, Abdel Rahman El Sheikh ^a   Ahmed, Abdul Mutaal Mohamed ^a   Shariq, Sohail ^a   Yasawy, Mohamed Ismail ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

Esophageal varices; Schistosomiasis; Sclerotherapy; Viral hepatitis

Indexed keywords

MONOETHANOLAMINE OLEATE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CAUSE OF DEATH; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; DISEASE CLASSIFICATION; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; FEMALE; HEPATITIS B; HUMAN; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PERFORATION; PORTAL HYPERTENSION; PRIORITY JOURNAL; SCHISTOSOMIASIS; SURVIVAL TIME; ULCER;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEPATITIS B; HUMANS; LIVER DISEASES; LIVER DISEASES, PARASITIC; MALE; MIDDLE AGED; RECURRENCE; SCHISTOSOMIASIS; SCLEROTHERAPY; TREATMENT OUTCOME;

EID: 9044224395     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Al Karawi MA: Mohamed Sclerotherapy of bleeding oesophageal varices in schistosomiasis Saudi Medical Journal 1988; 9 (2): 394-399.
2. Mohamed AE, Al Karawi MA, Otaibi R, Hamid MA: Results of sclerotherapy in 100 patients. Comparison of the outcome between schistosomiasis and hepatitis B. Hepato-Gastroenterol 1989; 36: 333-336.
3. Hashizume M, Kitano S, Koyanagi N, et al: Endoscopic injection sclerotherapy for 1000 patients with oesophageal varices: A nine year prospective study Hepatology 1992; 15(1): 69-75.
4. Westaby D, MacDougall BRD, Williams R: Improved Survival following injection sclerotherapy for oesohageal varices: Final analysis of a controlled trial Hepatology 1985; 5: 827-830.
5. Arfaa F: Studies on schistosomiasis in Saudi Arabia AM J Tropical Med. & Hyg. 1986; 25: 295-298.
6. El Hazmi MA Hepatitis B: Markers in Saudi Arabia: A comparative study in different regions Annals of Saudi Medicine 1984; 6: 499-452.
7. Al Karawi MA, Shariq S, Mohamed AE, Saeed AA, Ahmed AMM: Hepatitis C Virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia Journal of Gastroenterology and Hepatology 1992; 7: 237-239.
8. Saeed AA, Ahmed AMM, Al Karawi MA, Mohamed AE, Al Saud AA, Shariq S: The association between hepatitis C virus antibody and hepatocellular carcinoma in relation to hepatitis B viral infection (RAFH Experience) Annals of Saudi Medicine 1992; 12 (3): 283-285.
9. Sakai P, Boaventura S, Capacci ML Macedo TM, Ishioka SZ: Endoscopic sclerotherapy of bleeding oesophageal varices. A comparative study of results in patients with schistosomiasis and cirrhosis Endoscopy 1988; 20: 134-136.
10. Child CG, Turcotte JG: Surgery and Portal hypertension. In: Child CG (ed) The liver and Portal hypertension WB Saunders Co, Philadelphia 1964: 50.
11. Kitano S, Hashizume M, Yamaga H, Higashi H, Sugimachi K: Sclerotherapy superior to surgery for longer survival and less re-bleeding in 103 cirrhotics with variceal bleeding Int Surg 1989; 74: 162-166.
12. The Copenhagen oesophageal varices sclerotherapy project: Sclerotherapy after first variceal haemorrhage in cirrhosis: A randomized multicenter trial N Engl J Med 1984; 311: 1594-1600.
13. Terblanche J, Barman PC, Kahn D, et al: Failure of repeated injection sclerotherapy to improve longterm survival after oesophageal bleeding; a five year prospective controlled trial Lancet 1983; 2: 1328-1332.
14. Korula J, Balart LA, Radvan G, Zweiban BE, Larson AW, Kao HW, Yamaza S: A prospective controlled clinical trial of chronic oesophageal variceal sclerotherapy Hepatology 1985; 5: 584-589.
15. Coutinho A: Haemodynamic studies on portal hypertension in schistosimiasis Am J Med 1968; 44: 547.